Back to Search
HARLEY KAUFMAN, M.D.
M.D.
Nuclear Medicine Physician
NPI: 1871550467Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
135584(NY)
Nuclear Medicine PhysicianPrimary
Nuclear Medicine
Code: 207U00000X
135584(NY)
Research & Publications (20)
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.
PMID 19128501·J Transl Med·2009
3-trial
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer.
PMID 18676757·Clin Cancer Res·2008
3-trial
Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer.
PMID 18039393·J Transl Med·2007
3-trial
Local delivery of vaccinia virus expressing multiple costimulatory molecules for the treatment of established tumors.
PMID 16454657·Hum Gene Ther·2006
3-trial
Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma.
PMID 15937544·J Clin Invest·2005
3-trial
Optimizing prostate cancer treatment by combining local radiation therapy with systemic vaccination.
PMID 16203760·Clin Cancer Res·2005
6-review
Manipulating the local tumor microenvironment with poxviruses expressing costimulatory molecules.
PMID 16461787·Ann N Y Acad Sci·2005
6-review
Panniculitis after vaccination against CEA and MUC1 in a patient with pancreatic cancer.
PMID 15629278·Lancet Oncol·2005
5-case
Immune system versus tumor: shifting the balance in favor of DCs and effective immunity.
PMID 14991063·J Clin Invest·2004
7-preclinical
Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group.
PMID 15169798·J Clin Oncol·2004
3-trial
Clinical protocol. Intra-Lesional rF-B7.1 versus rF-TRICOM vaccine in the treatment of metastatic cancer.
PMID 12804142·Hum Gene Ther·2003
8-other
Combination interleukin-2 and interleukin-12 induces severe gastrointestinal toxicity and epithelial cell apoptosis in mice.
PMID 11886170·Cytokine·2002
7-preclinical
Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity.
PMID 11906776·Vaccine·2002
7-preclinical
A phase I trial of intralesional rV-Tricom vaccine in the treatment of malignant melanoma.
PMID 11485637·Hum Gene Ther·2001
8-other
A phase I trial of intra lesional RV-B7.1 vaccine in the treatment of malignant melanoma.
PMID 10811235·Hum Gene Ther·2000
3-trial
Immunotherapy for pancreatic cancer: current concepts.
PMID 12063825·Hematol Oncol Clin North Am·2002
6-review
A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva.
PMID 19608530·Invest Ophthalmol Vis Sci·2009
2-rct
Perineal injuries at a large urban trauma center: injury patterns and outcomes.
PMID 19385292·Am Surg·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 423 E 23RD ST
NEW YORK, NY 10010 - Phone
- (212) 686-7500
Quick Facts
- NPI
- 1871550467
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile